CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Novartis Pharmaceuticals Corporation v. Dr. Reddy's Laboratories Ltd.

1:14-cv-01283

Overview

Case Number 1:14-cv-01283
Filing Date 2014-10-08
Status Terminated
Termination Date 2015-06-22
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Dr. Reddy's Laboratories Inc. Operating Company

Represented By

1 Attorneys Listed

Robert Karl Beste , III

Smith, Katzenstein, & Jenkins LLP

Tel: +1 (302) 652-8400
Fax: +1 (302) 652-8405

The Corporate Plaza, 800 Delaware Ave.

Novartis AG Operating Company

Represented By

2 Attorneys Listed

Daniel M. Silver

McCarter & English, LLP

Tel: +1 (302) 984-6300
Fax: +1 (302) 691-1260

Renaissance Centre, 405 N. King Street, 8th Floor

Michael P. Kelly

McCarter & English, LLP

Tel: +1 (302) 984-6300
Fax: +1 (302) 984-6399

Renaissance Centre, 405 N. King Street, 8th Floor

Novartis Pharmaceuticals Corporation Operating Company

Represented By

3 Attorneys Listed

Daniel M. Silver

McCarter & English, LLP

Tel: +1 (302) 984-6300
Fax: +1 (302) 691-1260

Renaissance Centre, 405 N. King Street, 8th Floor

Michael P. Kelly

McCarter & English, LLP

Tel: +1 (302) 984-6300
Fax: +1 (302) 984-6399

Renaissance Centre, 405 N. King Street, 8th Floor

David K. Barr

Email: david.barr@arnoldporter.com

Counter Claimant

Dr. Reddy's Laboratories Ltd. Operating Company

Represented By

1 Attorneys Listed

Robert Karl Beste , III

Smith, Katzenstein, & Jenkins LLP

Tel: +1 (302) 652-8400
Fax: +1 (302) 652-8405

The Corporate Plaza, 800 Delaware Ave.

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 6 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts Counterparts in force
πŸ›οΈ
USPTO PTAB Trials Counterparts in force
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (6): πŸ‡ΊπŸ‡Έ US 🌐 PCT
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

2 Patents

There are 2 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US6894051
Crystal modification of a N-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use
Filed: 1998-07-16
Issued: 2005-05-17
Expired (Term Ended) +311d PTA
Expires: 2019-05-23
USRE43392
Capability spoofing using a local proxy server
Filed: 2010-01-04
Issued: 2012-05-15
Expired (Term Ended)
Expires: 2024-12-31

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Statutorily Barred

Statutorily Barred β€” Patent expired. Under 35 U.S.C. Β§ 283, injunctive relief is barred.

Terminal Disclaimer & Cellect Risk Scrutiny / Risk

High PTA (+311 days) / In re Cellect scrutiny applies.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

2

Dispositive

0

Granted

0

Denied

0

Pending / Review

2

Motions by Category

Procedural / Extension Motion 2

Key Dispositive Motions & Rulings

Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME regarding the Deadline for the Parties to Submit a Proposed Scheduling Order to Wednesday, July 8, 2015 (from Friday, May 8, 2015) - ...
Entry #13 • 2015-05-05 Document →
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME for the Parties to Submit a Proposed Scheduling Order to Friday, May 8, 2015 (from Monday, March 9, 2015 in C.A. No. 14-157 and Monda...
Entry #12 • 2015-02-26 Document →

Docket Entries

(20 total)
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMENT filed against Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 311-1603841.) - filed by Novartis Pharmaceuticals Corporation, Novartis AG. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet)(dmp, ) (Entered: 10/09/2014)

Entry #1 • 2014-10-08
1
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMENT filed against Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 311-1603841.) - filed by Novartis Pharmaceuticals Corporation, Novartis AG. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet)(dmp, ) (Entered: 10/09/2014)

Entry #1 • 2014-10-08
2
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMENT filed against Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 311-1603841.) - filed by Novartis Pharmaceuticals Corporation, Novartis AG. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet)(dmp, ) (Entered: 10/09/2014)

Entry #1 • 2014-10-08
2
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMENT filed against Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 311-1603841.) - filed by Novartis Pharmaceuticals Corporation, Novartis AG. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet)(dmp, ) (Entered: 10/09/2014)

Entry #1 • 2014-10-08
2

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (dmp, ) (Entered: 10/09/2014)

Entry #2 • 2014-10-08
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc